| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/29/2001 | WO2000077220A3 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000073430A3 Vaccines against conformation-dependent antigens and against antigens that are not or are not only proteins or peptides |
| 03/29/2001 | WO2000064939A3 Peptides derived from vasostatin i and the use thereof as anti-fungal agents |
| 03/29/2001 | WO2000063386A3 Prevention, diagnosis and treatment of lyme disease |
| 03/29/2001 | WO2000061742A3 Treatment of cardiac power failure using s100 proteins |
| 03/29/2001 | WO2000052161A3 Leukocyte- and blood-associated proteins |
| 03/29/2001 | WO2000052148A3 Substances for controlling fertility |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO2000034436A9 Facs assisted methods for introducing individual chromosomes into cells |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | WO2000023615A3 Method for extracting quantitative information relating to an influence on a cellular response |
| 03/29/2001 | WO2000020607A9 Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | WO1999063088A3 Membrane-bound proteins and nucleic acids encoding the same |
| 03/29/2001 | WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/29/2001 | US20010000077 Reacting under isotactic conditions a nucleic acid having a specific sequence with a mixture of nucleic acid precursors, complementary specific nucleic acid dimers and a nucleic acid catalyst, e.g. polymerase or reverse transcriptase |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | DE19962508A1 Verfahren zur Identifizierung von MHC-Restringierten Antigenen A method for identifying of MHC-restricted antigens |
| 03/29/2001 | DE19946296A1 Multiplex-PCR zum Nachweis von EHEC-Infektionen Multiplex PCR for detection of EHEC infections |
| 03/29/2001 | DE19946142A1 Cell-targeting vector selective for T lymphocytes, useful in gene therapy of e.g. acquired immune deficiency syndrome, encodes a single-chain variable antibody fragment |
| 03/29/2001 | DE19946047A1 Proteinproduktion mit Ashbya gossypii Protein production using Ashbya gossypii |
| 03/29/2001 | DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium |
| 03/29/2001 | DE19943374A1 Verfahren zum Anbinden von Nukleinsäuren an eine Festphase Mechanism for attaching nucleic acids to a solid phase |
| 03/29/2001 | DE19937548A1 Ein- oder mehrzellige Organismen zur Herstellung von Riboflavin Mono- or multicellular organisms for the production of riboflavin |
| 03/29/2001 | CA2847143A1 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | CA2404709A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 03/29/2001 | CA2388365A1 Helper vectors and cell lines for the production of pseudoadenoviral vectors |
| 03/29/2001 | CA2387695A1 A novel member of the heparanase protein family |
| 03/29/2001 | CA2386767A1 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385851A1 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/29/2001 | CA2385813A1 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 03/29/2001 | CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | CA2385778A1 Modulation of ige receptor cell surface expression |
| 03/29/2001 | CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | CA2385664A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385497A1 Methods and microorganisms for production of panto-compounds |
| 03/29/2001 | CA2385484A1 Site-specific recombination system to manipulate the plastid genome of higher plants |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385425A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385406A1 Gene encoding novel human secretory phospholipase a2 |
| 03/29/2001 | CA2385377A1 Method to identify compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385231A1 Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof |
| 03/29/2001 | CA2385228A1 Ribozymes used for restenosis prevention |
| 03/29/2001 | CA2385072A1 Method for genetic modification of lactobacillus delbrueckii |
| 03/29/2001 | CA2385029A1 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 03/29/2001 | CA2384973A1 Seed-preferred promoter from maize |
| 03/29/2001 | CA2384932A1 Targeted gene removal |
| 03/29/2001 | CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2384828A1 Methods for producing recombinant proteins |
| 03/29/2001 | CA2384827A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | CA2384806A1 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383433A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | CA2383253A1 Conditional immortalisation of cells |
| 03/29/2001 | CA2383093A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | CA2381020A1 Cis-prenyltransferases from plants |
| 03/29/2001 | CA2350700A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/28/2001 | EP1087020A2 Universal probes and methods for detection of nucleic acids |
| 03/28/2001 | EP1087017A2 The cytoplasmic inhibition of gene expression |
| 03/28/2001 | EP1087016A2 Agrobacterium tumefaciens transformation of musa species |
| 03/28/2001 | EP1087015A2 Cloning and uses of a novel nucleotide sequence coding for glucose-6-phosphate isomerase (gpi) from bacteria |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1087012A1 Groups of genes expressed in human dendritic cells |
| 03/28/2001 | EP1086956A1 Gene recombinant antibodies |
| 03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
| 03/28/2001 | EP1086494A1 Infrared thermography |
| 03/28/2001 | EP1086485A2 Process and manufacturing tool architecture for use in the manufacture of one or more metallization levels on a workpiece |
| 03/28/2001 | EP1086377A1 A method of identifying ligands to rna polymerase sigma 70 subunit |
| 03/28/2001 | EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt) |
| 03/28/2001 | EP1086250A2 Method of generating nucleic acid hybrids for mutation analysis |
| 03/28/2001 | EP1086249A2 Diagnostic method based on quantification of extramitochondrial dna |
| 03/28/2001 | EP1086248A1 Denaturing gradient affinity electrophoresis and methods of use thereof |
| 03/28/2001 | EP1086245A2 Multi-fluorescent hairpin energy transfer oligonucleotides |
| 03/28/2001 | EP1086244A1 Restriction enzyme gene discovery method |
| 03/28/2001 | EP1086240A1 Methods for testing biological network models |
| 03/28/2001 | EP1086239A1 Formulations for electroporation |
| 03/28/2001 | EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 03/28/2001 | EP1086237A2 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter |
| 03/28/2001 | EP1086236A2 Polyunsaturated fatty acids in plants |
| 03/28/2001 | EP1086235A2 Corn oleosin promoter and genes encoding corn desaturases |
| 03/28/2001 | EP1086234A1 New human carboxypeptidase inhibitor |
| 03/28/2001 | EP1086233A2 Cloning of human choline / ethanolaminephospho - transferases; synthesis of phosphatidyl - choline, phosphatidyle - thanolamine, and platelet activating factor |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086231A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086229A2 Moraxella catarrhalis polynucleotides and polypeptides |